Results 141 to 150 of about 361,079 (214)

Effectiveness of Pneumococcal Conjugate Vaccines Over Antibiotic-Resistant Acute Otitis Media in Children: A Systematic Review. [PDF]

Cureus
Dissanayake G, Zergaw M, Elgendy M, Billey A, Saleem A, Zeeshan B, Nassar ST.   +6 more
europepmc   +1 more source

Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. [PDF]

MMWR Morb Mortal Wkly Rep
Kobayashi M, Leidner AJ, Gierke R, Xing W, Accorsi E, Moro P, Kamboj M, Kuchel GA, Schechter R, Loehr J, Cohen AL.   +10 more
europepmc   +1 more source

Assessing the Impact of Pneumococcal Conjugate Vaccines

Clinical Infectious Diseases, 2019
openaire   +2 more sources

Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children. [PDF]

Nat Commun
Lekhuleni C, Ndlangisa K, Gladstone RA, Chochua S, Metcalf BJ, Li Y, Kleynhans J, de Gouveia L, Hazelhurst S, Ferreira ADS, Skosana H, Walaza S, Quan V, Meiring S, Hawkins PA, McGee L, Bentley SD, Cohen C, Lo SW, von Gottberg A, du Plessis M.   +20 more
europepmc   +1 more source

An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population. [PDF]

Hum Vaccin Immunother
Fridh AC, Palmborg A, Ta A, Freigofaite D, Warren S, Perdrizet J.   +5 more
europepmc   +1 more source

Similarities and Differences Between Countries When Estimating the Effect of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media. [PDF]

Pediatr Infect Dis J
Levy C, Varon E, Béchet S, Bonacorsi S, Cohen R.   +4 more
europepmc   +1 more source

Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media. [PDF]

Pediatr Infect Dis J
Kaur R, Schulz S, Sherman A, Andrejko K, Kobayashi M, Pichichero M.   +5 more
europepmc   +1 more source

Serotype distribution of invasive and non-invasive pneumococcal disease in adults ≥65 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review. [PDF]

Front Public Health
Izurieta P, Borys D.
europepmc   +1 more source

Serotype distribution of invasive and non-invasive pneumococcal disease in children ≤5 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review. [PDF]

Front Public Health
Izurieta P, AbdelGhany M, Borys D.
europepmc   +1 more source

Potential Impact of Higher-Valency Pneumococcal Conjugate Vaccines Among Adults in Different Localities in Germany. [PDF]

J Infect Dis
Ellingson MK, Weinberger DM, van der Linden M, Perniciaro S.   +3 more
europepmc   +1 more source